Issued Patents All Time
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6818622 | Selective MMP inhibitors having reduced side-effects | John M. Bird, John Gary Montana, Ruth Elizabeth Wills, Andrew Douglas Baxter | 2004-11-16 |
| 6734189 | Hydroxamic and carboxylic acid derivatives | Duncan Batty, Verity Margaret Sabin, Robert J. Watson, Hazel Joan Dyke, Andrew Sharpe +2 more | 2004-05-11 |
| 6706719 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | Andrew Douglas Baxter, Robert J. Watson | 2004-03-16 |
| 6680338 | Hydroxamic and carboxylic acid derivatives | John Gary Montana, Andrew Douglas Baxter, Robert J. Watson | 2004-01-20 |
| 6566384 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | John Gary Montana, John Keily, Robert J. Watson, Andrew Douglas Baxter | 2003-05-20 |
| 6506764 | Hydroxamic and carboxylic acid derivatives | Andrew Douglas Baxter, Duncan Hannah, John Gary Montana | 2003-01-14 |
| 6503910 | Hydroxamic and carboxylic acid derivatives | Andrew Douglas Baxter, Robert J. Watson, John Gary Montana | 2003-01-07 |
| 6469020 | Hydroxamic and carboxylic acid derivatives | Duncan Batty, Verity Margaret Sabin, Robert J. Watson, Hazel Joan Dyke, Andrew Sharpe +2 more | 2002-10-22 |
| 6465468 | Hydroxamic and carboxylic acid derivatives | Andrew Douglas Baxter, Duncan Batty, Robert J. Watson | 2002-10-15 |
| 6462042 | Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors | Andrew Douglas Baxter, Robert J. Watson, John Gary Montana | 2002-10-08 |
| 6455531 | Hydroxamic acid derivatives | Andrew Douglas Baxter, Robert J. Watson, Duncan Hannah, John Gary Montana | 2002-09-24 |
| 6310088 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | Andrew Douglas Baxter, John Gary Montana, Elizabeth Jane Reed Nicholson | 2001-10-30 |
| 6187924 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | Andrew Douglas Baxter, John Gary Montana, Robert J. Watson | 2001-02-13 |
| 6180611 | Peptidyl compounds | John Gary Montana, Andrew Douglas Baxter, Robert J. Watson, Neil Phillipson | 2001-01-30 |
| 6118001 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | John Gary Montana, John Keily, Robert J. Watson, Andrew Douglas Baxter | 2000-09-12 |
| 6114372 | Peptidyl compounds having MMP and TNF inhibitory activity | Andrew Douglas Baxter, John Gary Montana, Robert J. Watson, John Keily | 2000-09-05 |
| 6110896 | Peptidyl compounds and their therapeutic use | Andrew Douglas Baxter, John Gary Montana | 2000-08-29 |
| 6100266 | Hydroxamic and carboxylic acid derivatives | John Gary Montana, Andrew Douglas Baxter | 2000-08-08 |
| 6090840 | Peptidyl compounds having MMP and TNF inhibitory activity | Andrew Douglas Baxter, John Gary Montana, Robert J. Watson, John Keily | 2000-07-18 |
| 6063786 | Heterocyclic compounds having MMP and TNF inhibitory activity | Andrew Douglas Baxter, John Gary Montana | 2000-05-16 |
| 5994293 | Peptidyl compounds and their therapeutic use | Andrew Douglas Baxter, John Gary Montana | 1999-11-30 |
| 5994312 | Peptidyl compounds | John Gary Montana, Andrew Douglas Baxter, Robert J. Watson, Neil Phillipson | 1999-11-30 |
| 5981490 | Peptidyl compounds | Andrew Douglas Baxter, John Gary Montana | 1999-11-09 |
| 5981491 | Peptidyl compounds and their therapeutic use | Andrew Douglas Baxter, John Gary Montana | 1999-11-09 |
| 5872146 | Mercapto alkyl peptidyl compounds having MMP and TNF inhibitory activity | Andrew Douglas Baxter, John Gary Montana | 1999-02-16 |